{"id":"https://openalex.org/W2921452985","doi":"https://doi.org/10.1117/12.2513648","title":"Quantitative vessel tortuosity radiomics on baseline non-contrast lung CT predict response to immunotherapy and are prognostic of overall survival","display_name":"Quantitative vessel tortuosity radiomics on baseline non-contrast lung CT predict response to immunotherapy and are prognostic of overall survival","publication_year":2019,"publication_date":"2019-03-13","ids":{"openalex":"https://openalex.org/W2921452985","doi":"https://doi.org/10.1117/12.2513648","mag":"2921452985"},"language":"en","primary_location":{"id":"doi:10.1117/12.2513648","is_oa":false,"landing_page_url":"https://doi.org/10.1117/12.2513648","pdf_url":null,"source":{"id":"https://openalex.org/S4306519510","display_name":"Medical Imaging 2019: Computer-Aided Diagnosis","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Imaging 2019: Computer-Aided Diagnosis","raw_type":"proceedings-article"},"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107993151","display_name":"Mehdi Alilou","orcid":"https://orcid.org/0000-0002-0119-7322"},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehdi Alilou","raw_affiliation_strings":["Case Western Reserve Univ. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve Univ. (United States)","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088228366","display_name":"Kaustav Bera","orcid":"https://orcid.org/0000-0001-9831-6000"},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaustav Bera","raw_affiliation_strings":["Case Western Reserve Univ. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve Univ. (United States)","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007655291","display_name":"Pranjal Vaidya","orcid":"https://orcid.org/0000-0002-7146-6049"},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pranjal Vaidya","raw_affiliation_strings":["Case Western Reserve Univ. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve Univ. (United States)","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067928290","display_name":"Alexia Zagouras","orcid":"https://orcid.org/0000-0003-0899-0910"},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexia Zagouras","raw_affiliation_strings":["Cleveland Clinic Foundation (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation (United States)","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033238361","display_name":"Pradnya D. Patil","orcid":"https://orcid.org/0000-0003-1304-3678"},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pradnya Patil","raw_affiliation_strings":["Cleveland Clinic Foundation (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic Foundation (United States)","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035645374","display_name":"Mohammadhadi Khorrami","orcid":"https://orcid.org/0000-0002-4141-8548"},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohammadhadi Khorrami","raw_affiliation_strings":["Case Western Reserve Univ. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve Univ. (United States)","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059061070","display_name":"Pingfu Fu","orcid":"https://orcid.org/0000-0002-2334-5218"},"institutions":[{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Pingfu Fu","raw_affiliation_strings":["Case Western Reserve Univ. (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve Univ. (United States)","institution_ids":["https://openalex.org/I58956616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066861614","display_name":"Vamsidhar Velcheti","orcid":"https://orcid.org/0000-0002-6589-0759"},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vamsidhar Velcheti","raw_affiliation_strings":["NYU Langone (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NYU Langone (United States)","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027642699","display_name":"Anant Madabhushi","orcid":"https://orcid.org/0000-0002-5741-0399"},"institutions":[{"id":"https://openalex.org/I4210110978","display_name":"Louis Stokes Cleveland VA Medical Center","ror":"https://ror.org/01vrybr67","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210110978","https://openalex.org/I4210127612"]},{"id":"https://openalex.org/I58956616","display_name":"Case Western Reserve University","ror":"https://ror.org/051fd9666","country_code":"US","type":"education","lineage":["https://openalex.org/I58956616"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anant Madabhushi","raw_affiliation_strings":["Case Western Reserve Univ. (United States)","Louis Stokes Cleveland Veterans Administration Medical Ctr.  (United States)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Case Western Reserve Univ. (United States)","institution_ids":["https://openalex.org/I58956616"]},{"raw_affiliation_string":"Louis Stokes Cleveland Veterans Administration Medical Ctr.  (United States)","institution_ids":["https://openalex.org/I4210110978"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.7575,"has_fulltext":false,"cited_by_count":13,"citation_normalized_percentile":{"value":0.84466143,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":97},"biblio":{"volume":null,"issue":null,"first_page":"51","last_page":"51"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12422","display_name":"Radiomics and Machine Learning in Medical Imaging","score":0.9998000264167786,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12422","display_name":"Radiomics and Machine Learning in Medical Imaging","score":0.9998000264167786,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9979000091552734,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10073","display_name":"Hepatocellular Carcinoma Treatment and Prognosis","score":0.9912999868392944,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/medicine","display_name":"Medicine","score":0.7752665281295776},{"id":"https://openalex.org/keywords/nivolumab","display_name":"Nivolumab","score":0.7643723487854004},{"id":"https://openalex.org/keywords/oncology","display_name":"Oncology","score":0.5796353220939636},{"id":"https://openalex.org/keywords/internal-medicine","display_name":"Internal medicine","score":0.5732146501541138},{"id":"https://openalex.org/keywords/radiomics","display_name":"Radiomics","score":0.5290821194648743},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"Immunotherapy","score":0.5264105200767517},{"id":"https://openalex.org/keywords/response-evaluation-criteria-in-solid-tumors","display_name":"Response Evaluation Criteria in Solid Tumors","score":0.4930715262889862},{"id":"https://openalex.org/keywords/durvalumab","display_name":"Durvalumab","score":0.48846760392189026},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"Lung cancer","score":0.45867428183555603},{"id":"https://openalex.org/keywords/radiology","display_name":"Radiology","score":0.4038761258125305},{"id":"https://openalex.org/keywords/progressive-disease","display_name":"Progressive disease","score":0.3272108733654022},{"id":"https://openalex.org/keywords/cancer","display_name":"Cancer","score":0.2393995225429535},{"id":"https://openalex.org/keywords/disease","display_name":"Disease","score":0.23700082302093506}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7752665281295776},{"id":"https://openalex.org/C2780030458","wikidata":"https://www.wikidata.org/wiki/Q7041828","display_name":"Nivolumab","level":4,"score":0.7643723487854004},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5796353220939636},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5732146501541138},{"id":"https://openalex.org/C2778559731","wikidata":"https://www.wikidata.org/wiki/Q23808793","display_name":"Radiomics","level":2,"score":0.5290821194648743},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5264105200767517},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.4930715262889862},{"id":"https://openalex.org/C2777742743","wikidata":"https://www.wikidata.org/wiki/Q19904005","display_name":"Durvalumab","level":5,"score":0.48846760392189026},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.45867428183555603},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.4038761258125305},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.3272108733654022},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2393995225429535},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.23700082302093506}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1117/12.2513648","is_oa":false,"landing_page_url":"https://doi.org/10.1117/12.2513648","pdf_url":null,"source":{"id":"https://openalex.org/S4306519510","display_name":"Medical Imaging 2019: Computer-Aided Diagnosis","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Imaging 2019: Computer-Aided Diagnosis","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.6600000262260437,"id":"https://metadata.un.org/sdg/10","display_name":"Reduced inequalities"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1238092070","https://openalex.org/W1974176583","https://openalex.org/W1991235944","https://openalex.org/W1994670953","https://openalex.org/W2005031684","https://openalex.org/W2005992530","https://openalex.org/W2009911194","https://openalex.org/W2063556542","https://openalex.org/W2066671159","https://openalex.org/W2126901657","https://openalex.org/W2128739912","https://openalex.org/W2136859769","https://openalex.org/W2205394859","https://openalex.org/W2531571306","https://openalex.org/W2562844176","https://openalex.org/W2735874307","https://openalex.org/W2766285328","https://openalex.org/W2786052636","https://openalex.org/W2800038717","https://openalex.org/W2895880339","https://openalex.org/W2917837889","https://openalex.org/W4236256952","https://openalex.org/W4238029108","https://openalex.org/W6745628544","https://openalex.org/W6759431858"],"related_works":["https://openalex.org/W3017309209","https://openalex.org/W4361812027","https://openalex.org/W3035064981","https://openalex.org/W2769465923","https://openalex.org/W2897254871","https://openalex.org/W1584669207","https://openalex.org/W2024340610","https://openalex.org/W2899528185","https://openalex.org/W2791043965","https://openalex.org/W3031735911"],"abstract_inverted_index":{"Recently":[0],"immune-checkpoint":[1],"inhibitors":[2,87,128],"have":[3],"demonstrated":[4],"promising":[5],"clinical":[6],"efficacy":[7],"in":[8,29,36,67,103,179,204],"patients":[9,56,133,149,187,238],"with":[10,134,137,206,223,239],"advanced":[11],"non-small":[12],"cell":[13],"lung":[14],"cancer":[15],"(NSCLC).":[16],"However,":[17],"the":[18,30,37,69,77,213,247],"response":[19,84,125,171,191,220],"rates":[20],"to":[21,47,52,82,85,123,126,167,218,221],"immune":[22],"checkpoint":[23,86,127],"blockade":[24],"drugs":[25],"remain":[26],"modest":[27],"(45%":[28],"front":[31],"line":[32,39],"setting":[33],"and":[34,73,107,129,154,242],"20%":[35],"second":[38],"setting).":[40],"Consequently,":[41],"there":[42,62],"is":[43],"an":[44,224],"unmet":[45],"need":[46],"develop":[48],"accurate,":[49],"validated":[50],"biomarkers":[51],"predict":[53,83,124,219],"which":[54],"NSCLC":[55,135],"will":[57],"benefit":[58],"from":[59],"immunotherapy.":[60],"While":[61],"has":[63,92],"been":[64],"recent":[65],"interest":[66],"evaluating":[68],"role":[70,102],"of":[71,76,147,170,226,234],"texture":[72],"shape":[74],"patterns":[75],"nodule":[78,95],"on":[79,142],"CT":[80],"scans":[81],"for":[88,132],"NSCLC,":[89],"our":[90],"group":[91],"shown":[93],"that":[94],"vessel":[96,119],"morphology":[97],"might":[98],"also":[99],"play":[100],"a":[101,114,143,168,207],"determining":[104],"tumor":[105],"aggressiveness":[106],"behavior.":[108],"In":[109],"this":[110],"work":[111],"we":[112],"present":[113],"new":[115],"approach":[116],"using":[117],"quantitative":[118],"tortuosity":[120],"(QVT)":[121],"radiomics,":[122],"overall":[130,235],"survival":[131,236],"treated":[136],"Nivolumab":[138,162],"(a":[139],"PD1":[140],"inhibitor)":[141],"retrospective":[144],"data":[145],"set":[146],"111":[148],"(D1)":[150],"including":[151],"56":[152],"responders":[153],"45":[155],"non-responders.":[156],"Patients":[157],"who":[158,188],"did":[159],"not":[160],"receive":[161],"after":[163],"2":[164],"cycles":[165],"due":[166],"lack":[169],"or":[172,192],"progression":[173],"as":[174,185,195,200],"per":[175,196],"Response":[176],"Evaluation":[177],"Criteria":[178],"Solid":[180],"Tumors":[181],"(RECIST)":[182],"were":[183,198,216],"classified":[184,199],"non-responders,":[186],"had":[189],"radiological":[190],"stable":[193],"disease":[194],"RECIST":[197],"responders.":[201],"On":[202],"D<sub>1</sub>,":[203],"conjunction":[205],"linear":[208],"discriminant":[209],"analysis":[210,230],"(LDA)":[211],"classifier":[212,249],"QVT":[214],"features":[215],"able":[217],"immunotherapy":[222],"AUC":[225],"0.73_0.04.":[227],"Kaplan":[228],"Meier":[229],"showed":[231],"significant":[232],"difference":[233],"between":[237],"low":[240],"risk":[241,244],"high":[243],"defined":[245],"by":[246],"radiomics":[248],"(p-value":[250],"=":[251],"0.004,":[252],"HR=":[253],"2.29,":[254],"95%":[255],"CI=":[256],"1.35":[257],"-":[258],"3.87).":[259]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1}],"updated_date":"2026-06-11T09:08:48.828518","created_date":"2025-10-10T00:00:00"}